首页 > 最新文献

Japanese Journal of Infection Prevention and Control最新文献

英文 中文
Usefulness of Rapid Diagnostic Tests for Infectious Diseases in Natural Disaster: Clinical Aspects and Management for Infection Prevention and Control 自然灾害中传染病快速诊断测试的有效性:感染预防和控制的临床方面和管理
Pub Date : 2021-05-25 DOI: 10.4058/jsei.36.127
T. Aoyagi
Japan is called a “disaster powerhouse,” as it is affected by natural disasters, such as earthquakes, tsunamis, torrential rains, and typhoons almost every year. Immediately after a disaster, wound infections and respiratory tract infections including pneumonia, which are related to trauma and drowning, arise health problems for victims. Thereafter, poor hygiene at the evacuation center and forced long-term living in overcrowded areas cause infections and outbreaks due to influenza virus and infectious gastroenteritis including norovirus. Infectious diseases after natural disasters are problems not only at an individual level but also in a community environment. It is necessary to accurately grasp which infectious disease is the problem after natural disaster, and we should apply effective medical treatment or infection control. In a situation where the lifeline after a natural disaster is insufficient and medical resources are limited, the identification of pathogenic microorganisms by point-of-care testing (POCT) using immunochromatography (such as Streptococcus pneumoniae and Legionella pneumophila by urinary antigen test, influenza virus antigen test, and norovirus antigen test) is reportedly useful for the treatment of infection and early detection and intervention of outbreaks in evacuation centers. It is expected that genetic testing will continue to spread in the field of infectious diseases in the future. However, currently, it is impossible to carry out genetic testing as a POCT after a natural disaster. Therefore, even in the absence of a disaster, it is necessary to closely examine past cases of infectious diseases after natural disasters and evaluate which POCT especially in immunochromatography have been established with infectious diseases.
日本几乎每年都会受到地震、海啸、暴雨、台风等自然灾害的影响,因此被称为“灾难强国”。灾难发生后,与创伤和溺水有关的伤口感染和呼吸道感染(包括肺炎)会立即给受害者带来健康问题。此后,疏散中心的卫生条件差和被迫长期居住在拥挤地区,导致流感病毒和感染性肠胃炎(包括诺如病毒)感染和暴发。自然灾害后的传染病不仅是个人层面的问题,而且也是社区环境的问题。有必要准确把握自然灾害后的问题是哪些传染病,并采取有效的药物治疗或感染控制。在自然灾害后生命线不足和医疗资源有限的情况下,利用免疫层析法通过护理点检测(POCT)识别病原微生物(如通过尿抗原检测肺炎链球菌和嗜肺军团菌、流感病毒抗原检测和诺如病毒抗原检测),据报告有助于治疗感染,并在疏散中心早期发现和干预疫情暴发。预计今后基因检测将继续在传染病领域得到推广。但是,目前还不可能在自然灾害发生后将基因检测作为POCT进行。因此,即使在没有自然灾害的情况下,也有必要仔细检查过去自然灾害后的传染病病例,并评估哪些POCT特别是免疫层析与传染病建立了联系。
{"title":"Usefulness of Rapid Diagnostic Tests for Infectious Diseases in Natural Disaster: Clinical Aspects and Management for Infection Prevention and Control","authors":"T. Aoyagi","doi":"10.4058/jsei.36.127","DOIUrl":"https://doi.org/10.4058/jsei.36.127","url":null,"abstract":"Japan is called a “disaster powerhouse,” as it is affected by natural disasters, such as earthquakes, tsunamis, torrential rains, and typhoons almost every year. Immediately after a disaster, wound infections and respiratory tract infections including pneumonia, which are related to trauma and drowning, arise health problems for victims. Thereafter, poor hygiene at the evacuation center and forced long-term living in overcrowded areas cause infections and outbreaks due to influenza virus and infectious gastroenteritis including norovirus. Infectious diseases after natural disasters are problems not only at an individual level but also in a community environment. It is necessary to accurately grasp which infectious disease is the problem after natural disaster, and we should apply effective medical treatment or infection control. In a situation where the lifeline after a natural disaster is insufficient and medical resources are limited, the identification of pathogenic microorganisms by point-of-care testing (POCT) using immunochromatography (such as Streptococcus pneumoniae and Legionella pneumophila by urinary antigen test, influenza virus antigen test, and norovirus antigen test) is reportedly useful for the treatment of infection and early detection and intervention of outbreaks in evacuation centers. It is expected that genetic testing will continue to spread in the field of infectious diseases in the future. However, currently, it is impossible to carry out genetic testing as a POCT after a natural disaster. Therefore, even in the absence of a disaster, it is necessary to closely examine past cases of infectious diseases after natural disasters and evaluate which POCT especially in immunochromatography have been established with infectious diseases.","PeriodicalId":414784,"journal":{"name":"Japanese Journal of Infection Prevention and Control","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131766958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Should Pharmacists Do to Contribute Their Expertise to Infection Control Activities? 药剂师应该如何为感染控制活动贡献他们的专业知识?
Pub Date : 2021-05-25 DOI: 10.4058/jsei.36.142
Nao Onodera
With the aim of preventing infectious disease occurrence and spread among patients and staff in hospitals, infection control greatly contributes to medical safety and the improvement of quality of care. Pharmacists play important roles in multidisciplinary initiatives regarding infection control. Pharmacists have been actively involved in infection control at Iwate Medical University Hospital, since a full-time pharmacist was assigned to the Infectious Disease Control Office in April 2004. They have been involved in initiatives such as the transmission-based zoning system, the comprehensive prescription management system for antibacterial agent use, and handwashing campaigns. In addition, the mission of board-certified infection control pharmacy specialists is to address the importance of taking comprehensive measures, including the proper use of antimicrobial drugs, disinfectants, and medical supplies. To leverage their expertise in infection control activities, pharmacists need to understand the reciprocal relationship between the infection control team and antimicrobial stewardship team and produce tangible outcomes. In this respect, pharmacists should shift their overemphasis from “information gathering and analysis” and to developing “plans.” To do so, they should observe infection control from a wider perspective and should propose plans based on scientific and pharmaceutical evidence and operate the activities efficiently, with proper evaluation, for successful results.
感染控制的目的是防止传染病在医院的病人和工作人员中发生和传播,它大大有助于医疗安全和提高护理质量。药剂师在感染控制的多学科倡议中发挥着重要作用。自从2004年4月向传染病控制办公室指派了一名全职药剂师以来,药剂师一直积极参与岩手医科大学医院的感染控制工作。他们参与了诸如基于传播的分区制度、抗菌剂使用的综合处方管理制度和洗手运动等倡议。此外,经委员会认证的感染控制药学专家的任务是强调采取综合措施的重要性,包括正确使用抗菌药物、消毒剂和医疗用品。为了利用他们在感染控制活动中的专业知识,药剂师需要了解感染控制团队和抗菌药物管理团队之间的相互关系,并产生切实的成果。在这方面,药剂师应该把过分强调的从“信息收集和分析”转向制定“计划”。为此,他们应从更广泛的角度观察感染控制,并应根据科学和药物证据提出计划,并有效地开展活动,并进行适当的评估,以取得成功的结果。
{"title":"What Should Pharmacists Do to Contribute Their Expertise to Infection Control Activities?","authors":"Nao Onodera","doi":"10.4058/jsei.36.142","DOIUrl":"https://doi.org/10.4058/jsei.36.142","url":null,"abstract":"With the aim of preventing infectious disease occurrence and spread among patients and staff in hospitals, infection control greatly contributes to medical safety and the improvement of quality of care. Pharmacists play important roles in multidisciplinary initiatives regarding infection control. Pharmacists have been actively involved in infection control at Iwate Medical University Hospital, since a full-time pharmacist was assigned to the Infectious Disease Control Office in April 2004. They have been involved in initiatives such as the transmission-based zoning system, the comprehensive prescription management system for antibacterial agent use, and handwashing campaigns. In addition, the mission of board-certified infection control pharmacy specialists is to address the importance of taking comprehensive measures, including the proper use of antimicrobial drugs, disinfectants, and medical supplies. To leverage their expertise in infection control activities, pharmacists need to understand the reciprocal relationship between the infection control team and antimicrobial stewardship team and produce tangible outcomes. In this respect, pharmacists should shift their overemphasis from “information gathering and analysis” and to developing “plans.” To do so, they should observe infection control from a wider perspective and should propose plans based on scientific and pharmaceutical evidence and operate the activities efficiently, with proper evaluation, for successful results.","PeriodicalId":414784,"journal":{"name":"Japanese Journal of Infection Prevention and Control","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133065297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacokinetics of Antimicrobial Chemotherapy Based on Maturation in Children 基于成熟的儿童抗菌化疗药代动力学研究
Pub Date : 2021-03-25 DOI: 10.4058/jsei.36.77
Y. Tsuji
Numerically, the most significant difference between children and adults is body weight. Hu-mans are not born with complete physiological functions, and our body functions mature with growth. Assuming adult renal function to be 100%, glomerular filtration rate only reaches approximately 25%-40% of adult function at birth. Renal function reaches approximately 90% of adult function in the first year after birth and is comparable to adult function in the second year after birth. This review will discuss energy metabolism of living organisms, maturation from children to adults, pharmacokinetics in children, and describes antimicrobial chemotherapy in children.
在数字上,儿童和成人之间最显著的差异是体重。人的生理功能不是与生俱来的,我们的身体功能是随着成长而成熟的。假设成人肾功能100%,出生时肾小球滤过率仅达到成人功能的约25%-40%。肾脏功能在出生后第一年达到成人功能的约90%,并在出生后第二年与成人功能相当。这篇综述将讨论生物体的能量代谢,从儿童到成人的成熟,儿童的药代动力学,并描述儿童的抗菌化疗。
{"title":"Pharmacokinetics of Antimicrobial Chemotherapy Based on Maturation in Children","authors":"Y. Tsuji","doi":"10.4058/jsei.36.77","DOIUrl":"https://doi.org/10.4058/jsei.36.77","url":null,"abstract":"Numerically, the most significant difference between children and adults is body weight. Hu-mans are not born with complete physiological functions, and our body functions mature with growth. Assuming adult renal function to be 100%, glomerular filtration rate only reaches approximately 25%-40% of adult function at birth. Renal function reaches approximately 90% of adult function in the first year after birth and is comparable to adult function in the second year after birth. This review will discuss energy metabolism of living organisms, maturation from children to adults, pharmacokinetics in children, and describes antimicrobial chemotherapy in children.","PeriodicalId":414784,"journal":{"name":"Japanese Journal of Infection Prevention and Control","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126109252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Current Status of the Countermeasures to Prevent Infection with New Coronavirus Infections at Long-Term Care Welfare Facilities for Older Adults in Tochigi Prefecture, Japan 日本栃木县老年人长期护理福利机构预防新型冠状病毒感染的对策现状
Pub Date : 2021-03-25 DOI: 10.4058/JSEI.36.98
Teppei Sasahara
{"title":"The Current Status of the Countermeasures to Prevent Infection with New Coronavirus Infections at Long-Term Care Welfare Facilities for Older Adults in Tochigi Prefecture, Japan","authors":"Teppei Sasahara","doi":"10.4058/JSEI.36.98","DOIUrl":"https://doi.org/10.4058/JSEI.36.98","url":null,"abstract":"","PeriodicalId":414784,"journal":{"name":"Japanese Journal of Infection Prevention and Control","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129648094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approaches of Urologists Toward Treating Catheter-associated Urinary Tract Infections 泌尿科医师治疗导尿管相关性尿路感染的方法
Pub Date : 2021-03-25 DOI: 10.4058/jsei.36.83
H. Hotta
Catheter-associated urinary tract infections (CAUTI) account for 10%-20% of healthcare-associated infections. In the prevention of CAUTI, it is important that the urethral catheter is in-serted carefully, and residual urine is measured after removal of the urethral catheter. It is often difficult to determine the diagnosis of CAUTI in the elderly due to the lack of symptoms. Prior to the administration of an antimicrobial agent, the urethral catheter should be exchanged with a new one, and blood culture and urine culture data should be reported consistently. Treatment with antimicrobial agents should be selected based on the severity of CAUTI. qSOFA scores are useful in evaluating the severity. In this report, approaches to CAUTI are discussed from the urologistsʼ perspective.
导尿管相关性尿路感染(CAUTI)占医疗相关感染的10%-20%。在预防CAUTI中,重要的是小心插入导尿管,并在拔出导尿管后测量残余尿量。由于缺乏症状,老年人CAUTI的诊断往往难以确定。在使用抗菌药物前,应更换新的导尿管,并一致报告血培养和尿培养数据。应根据CAUTI的严重程度选择抗菌药物治疗。qSOFA分数在评估严重程度时很有用。在本报告中,从泌尿科医生的角度讨论了CAUTI的治疗方法。
{"title":"Approaches of Urologists Toward Treating Catheter-associated Urinary Tract Infections","authors":"H. Hotta","doi":"10.4058/jsei.36.83","DOIUrl":"https://doi.org/10.4058/jsei.36.83","url":null,"abstract":"Catheter-associated urinary tract infections (CAUTI) account for 10%-20% of healthcare-associated infections. In the prevention of CAUTI, it is important that the urethral catheter is in-serted carefully, and residual urine is measured after removal of the urethral catheter. It is often difficult to determine the diagnosis of CAUTI in the elderly due to the lack of symptoms. Prior to the administration of an antimicrobial agent, the urethral catheter should be exchanged with a new one, and blood culture and urine culture data should be reported consistently. Treatment with antimicrobial agents should be selected based on the severity of CAUTI. qSOFA scores are useful in evaluating the severity. In this report, approaches to CAUTI are discussed from the urologistsʼ perspective.","PeriodicalId":414784,"journal":{"name":"Japanese Journal of Infection Prevention and Control","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125291833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Responses to COVID-19 Clusters in Long-term Care Facilities of Japan 日本长期护理机构对COVID-19聚集性的应对
Pub Date : 2021-03-25 DOI: 10.4058/JSEI.36.92
Hiroaki Shiraishi, Yousuke Kinoshita, K. Miura
From April 21, 2020, 10 febrile individuals were recorded on the second floor of a 4-storey long-term care facility. SARS-CoV-2 PCR test confirmed that 9 were positive, and they were ad-mitted to our hospital. On April 27 of the same year, PCR tests were performed, and positive re-sults were obtained for, 21 residents, 1 short stay, and 6 staff members. Of these, 22 positive cases were quarantined on the second floor, and the negative cases were moved to the third and fourth floors. We performed zoning on the second and third floors and constructed a virtual ward on the electronic medical record in the hospital so that examinations and medication infu-sions could be ordered, and the residentʼs condition could be grasped at the hospital. Blood and urine tests were conducted at the facility, and if it was determined that a close examination was necessary, they were transferred to the hospital. A second PCR test was performed on 69 people on May 13, 2020, and 15 people from the second floor were positive, as well as three from the third floor who were then moved to the second floor. From May 27 to June 19, 2020, the PCR test was repeated four times, and it was determined that all residents were negative twice in a row and that the cluster had converged. Dur-ing this period, six people died due to complications, such as pneumonia and multiple organ fail-ure, with a mortality rate of 14.3%.
从2020年4月21日起,在一家4层长期护理机构的二楼记录了10例发热患者。SARS-CoV-2 PCR检测阳性9例,已入院治疗。同年4月27日进行PCR检测,结果为21名住院患者、1名短期住院患者和6名工作人员呈阳性。其中22例阳性病例被隔离在二楼,阴性病例被转移到三楼和四楼。我们对二楼和三楼进行分区,并在医院的电子病历上建立了一个虚拟病房,以便于安排检查和输液,并在医院掌握住院病人的病情。在该设施进行了血液和尿液检查,如果确定需要进行仔细检查,则将其转移到医院。2020年5月13日,对69人进行了第二次PCR检测,结果2楼15人呈阳性,3楼3人被转移到2楼。2020年5月27日至6月19日,重复4次PCR检测,确定所有居民连续2次呈阴性,聚集性趋同。在此期间,有6人死于肺炎和多器官衰竭等并发症,死亡率为14.3%。
{"title":"Responses to COVID-19 Clusters in Long-term Care Facilities of Japan","authors":"Hiroaki Shiraishi, Yousuke Kinoshita, K. Miura","doi":"10.4058/JSEI.36.92","DOIUrl":"https://doi.org/10.4058/JSEI.36.92","url":null,"abstract":"From April 21, 2020, 10 febrile individuals were recorded on the second floor of a 4-storey long-term care facility. SARS-CoV-2 PCR test confirmed that 9 were positive, and they were ad-mitted to our hospital. On April 27 of the same year, PCR tests were performed, and positive re-sults were obtained for, 21 residents, 1 short stay, and 6 staff members. Of these, 22 positive cases were quarantined on the second floor, and the negative cases were moved to the third and fourth floors. We performed zoning on the second and third floors and constructed a virtual ward on the electronic medical record in the hospital so that examinations and medication infu-sions could be ordered, and the residentʼs condition could be grasped at the hospital. Blood and urine tests were conducted at the facility, and if it was determined that a close examination was necessary, they were transferred to the hospital. A second PCR test was performed on 69 people on May 13, 2020, and 15 people from the second floor were positive, as well as three from the third floor who were then moved to the second floor. From May 27 to June 19, 2020, the PCR test was repeated four times, and it was determined that all residents were negative twice in a row and that the cluster had converged. Dur-ing this period, six people died due to complications, such as pneumonia and multiple organ fail-ure, with a mortality rate of 14.3%.","PeriodicalId":414784,"journal":{"name":"Japanese Journal of Infection Prevention and Control","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123326526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pollution Risk of Buffet-style Restaurants and Countermeasures ~Living with COVID-19~ 自助式餐厅的污染风险及对策~与新冠病毒共存~
Pub Date : 2021-03-25 DOI: 10.4058/JSEI.36.89
Y. Nakatani
{"title":"Pollution Risk of Buffet-style Restaurants and Countermeasures ~Living with COVID-19~","authors":"Y. Nakatani","doi":"10.4058/JSEI.36.89","DOIUrl":"https://doi.org/10.4058/JSEI.36.89","url":null,"abstract":"","PeriodicalId":414784,"journal":{"name":"Japanese Journal of Infection Prevention and Control","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130286056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determination of the Appropriate Dose of Vancomycin for Pediatric Patients with Cancer 小儿肿瘤患者万古霉素适宜剂量的确定
Pub Date : 2021-03-25 DOI: 10.4058/jsei.36.111
E. Suzuki, Jun Nishijo, Mami Oguchi, Katsuyuki Hori, Takemi Murai, Kisei Minami
Childhood cancers are associated with a high risk of infection due to the pathophysiology and adverse effects of anticancer drugs. Although vancomycin (VCM) is often used for treating cancer-associated infections, there are limited studies on VCM dosing in childhood cancers. Therefore, we retrospectively investigated VCM dosing administered to pediatric patients with cancer at Nagano Children’s Hospital. The trough values of the dose were compared with pharmacists’ therapeutic drug monitoring (TDM) intervention and the revised antimicrobial TDM guidelines. Between April 2011 and March 2017, pediatric patients with cancer aged 1-12 years who were administered VCM were enrolled in the study. The daily dose, number of doses, trough value of VCM, and serum creatinine level at the start and end of VCM administration were compared. The average daily doses significantly increased from 45.8 mg/kg/day at the beginning to 61.8 mg/kg/day at the end of therapy in 29 patients aged 1-6 years. The number of doses significantly increased from 3 to 4 times daily. The trough value of VCM significantly increased from 5.0 μg/mL to 10.0 μg/mL. The serum creatinine level remained unchanged from 0.21 mg/dL to 0.20 mg/dL. In nine patients aged 7-12 years, the daily dose increased from 46.1 mg/kg/day to 60.0 mg/kg/day. The number of doses remained unchanged 4 times a day. The trough value increased significantly from 6.5 μg/mL to 10.2 μg/mL. However, the serum creatinine level remained unchanged from 0.24 mg/dL to 0.25 mg/dL. In pediatric patients with cancer, VCM doses to reach the target value of a trough concentration of 10 μg/mL or more were started with an administration of 61.8 mg/kg/day (15.5 mg/kg, every 6 h) for children aged 1-6 years and 60.0 mg/kg/day (15.0 mg/kg, every 6 h) according to the revised guidelines for those aged 7-12 years. VCM might reach the target trough value by further TDM.
由于病理生理和抗癌药物的不良反应,儿童癌症与感染的高风险相关。虽然万古霉素(VCM)常用于治疗癌症相关感染,但关于儿童癌症中万古霉素剂量的研究有限。因此,我们回顾性地研究了长野儿童医院给儿童癌症患者的VCM剂量。将剂量谷值与药师治疗药物监测(TDM)干预和修订后的抗菌TDM指南进行比较。在2011年4月至2017年3月期间,接受VCM治疗的1-12岁儿童癌症患者参加了这项研究。比较两组患者的日剂量、给药次数、VCM波谷值及给药开始和结束时血清肌酐水平。29例1-6岁患者的平均日剂量从治疗开始时的45.8 mg/kg/天显著增加到治疗结束时的61.8 mg/kg/天。剂量从每天3次显著增加到4次。VCM波谷值由5.0 μg/mL显著升高至10.0 μg/mL。血清肌酐水平从0.21 mg/dL维持到0.20 mg/dL。在9例7-12岁的患者中,日剂量从46.1 mg/kg/天增加到60.0 mg/kg/天。剂量数量保持不变,每天4次。波谷值由6.5 μg/mL显著升高至10.2 μg/mL。然而,血清肌酐水平从0.24 mg/dL到0.25 mg/dL保持不变。在儿童癌症患者中,根据修订后的指南,1-6岁儿童的VCM剂量为61.8 mg/kg/天(15.5 mg/kg,每6小时),7-12岁儿童的VCM剂量为60.0 mg/kg/天(15.0 mg/kg,每6小时),以达到谷浓度10 μg/mL或更高的目标。通过进一步的TDM, VCM可能达到目标波谷值。
{"title":"Determination of the Appropriate Dose of Vancomycin for Pediatric Patients with Cancer","authors":"E. Suzuki, Jun Nishijo, Mami Oguchi, Katsuyuki Hori, Takemi Murai, Kisei Minami","doi":"10.4058/jsei.36.111","DOIUrl":"https://doi.org/10.4058/jsei.36.111","url":null,"abstract":"Childhood cancers are associated with a high risk of infection due to the pathophysiology and adverse effects of anticancer drugs. Although vancomycin (VCM) is often used for treating cancer-associated infections, there are limited studies on VCM dosing in childhood cancers. Therefore, we retrospectively investigated VCM dosing administered to pediatric patients with cancer at Nagano Children’s Hospital. The trough values of the dose were compared with pharmacists’ therapeutic drug monitoring (TDM) intervention and the revised antimicrobial TDM guidelines. Between April 2011 and March 2017, pediatric patients with cancer aged 1-12 years who were administered VCM were enrolled in the study. The daily dose, number of doses, trough value of VCM, and serum creatinine level at the start and end of VCM administration were compared. The average daily doses significantly increased from 45.8 mg/kg/day at the beginning to 61.8 mg/kg/day at the end of therapy in 29 patients aged 1-6 years. The number of doses significantly increased from 3 to 4 times daily. The trough value of VCM significantly increased from 5.0 μg/mL to 10.0 μg/mL. The serum creatinine level remained unchanged from 0.21 mg/dL to 0.20 mg/dL. In nine patients aged 7-12 years, the daily dose increased from 46.1 mg/kg/day to 60.0 mg/kg/day. The number of doses remained unchanged 4 times a day. The trough value increased significantly from 6.5 μg/mL to 10.2 μg/mL. However, the serum creatinine level remained unchanged from 0.24 mg/dL to 0.25 mg/dL. In pediatric patients with cancer, VCM doses to reach the target value of a trough concentration of 10 μg/mL or more were started with an administration of 61.8 mg/kg/day (15.5 mg/kg, every 6 h) for children aged 1-6 years and 60.0 mg/kg/day (15.0 mg/kg, every 6 h) according to the revised guidelines for those aged 7-12 years. VCM might reach the target trough value by further TDM.","PeriodicalId":414784,"journal":{"name":"Japanese Journal of Infection Prevention and Control","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124763011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial Stewardship Pharmacist-driven Prospective Audit and Feedback of All Intravenous Antibiotics in a Middle-sized Community Hospital 某中型社区医院抗菌药物管理药师主导的所有静脉注射抗生素前瞻性审核与反馈
Pub Date : 2021-03-25 DOI: 10.4058/jsei.36.117
Y. Sasaki, Akira Kurishima, Misato Amano, Ayumi Kanamaru, Akiko Yamakuchi, H. Takayasu, Yoshiro Hadano, Masataka Yano
{"title":"Antimicrobial Stewardship Pharmacist-driven Prospective Audit and Feedback of All Intravenous Antibiotics in a Middle-sized Community Hospital","authors":"Y. Sasaki, Akira Kurishima, Misato Amano, Ayumi Kanamaru, Akiko Yamakuchi, H. Takayasu, Yoshiro Hadano, Masataka Yano","doi":"10.4058/jsei.36.117","DOIUrl":"https://doi.org/10.4058/jsei.36.117","url":null,"abstract":"","PeriodicalId":414784,"journal":{"name":"Japanese Journal of Infection Prevention and Control","volume":"20 11","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120899661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examination of the Antibody Prevalence of Viral Diseases (Measles, Rubella, Chickenpox, and Mumps) among Staff in a Cancer Specialty Hospital 某癌症专科医院工作人员病毒性疾病(麻疹、风疹、水痘和腮腺炎)抗体流行率的检测
Pub Date : 2021-03-25 DOI: 10.4058/jsei.36.105
Haruka Utsunomiya, Izumi Nakagawa, M. Hamada
We examined the antibody prevalence of epidemic viral diseases among the employees (618) in our hospital using antibody titers measured for all of them. As a result, it was found that ap-proximately 70% of the employees should take measures such as investigation of vaccination history and additional vaccination though no one had negative antibody titers of all viral infections. The rate of our employees with a positive antibody titer meeting the measles criteria was 46.1% of the total. It showed that the risk of an outbreak was high if the measles was brought to our institution. However, more than 90% of the employees with a positive antibody titer met the chickenpox criteria, making it possible to release a small number of employees with being sus-ceptible to chicken pox from taking charge of patients with herpes zoster and disseminated herpes zoster. There was no gender difference in the prevalence of rubella antibody titers. The rate of our employees with a positive antibody titer meeting the mumps criteria was 59.3% of the to-tal, the second lowest after measles, while a concern had been growing about a possibility of an infection spread in the hospital next to measles. As a result of investigating a vaccination history of the employees in their 20s whose antibody titers did not meet the criteria, we confirmed that 66.7% of the employees had vaccination for measles and 56.5% for rubella. This suggested the presence of vaccine failure, including primary and secondary vaccine failure. It is important to investigate both antibody titer and vaccination history to confirm the status of acquisition of immunity. In the future, we need to review the vaccination history of all employees and recommend vaccinations based on the results.
对我院618名职工的流行性病毒性疾病的抗体流行情况进行了检测。结果发现,尽管所有病毒感染抗体滴度均为阴性,但仍有近70%的员工应采取调查疫苗接种史和补充疫苗接种等措施。抗体滴度阳性符合麻疹标准的员工占总数的46.1%。这表明,如果麻疹被带到我们的机构,爆发的风险很高。然而,抗体效价呈阳性的员工90%以上符合水痘标准,这使得有可能释放少数水痘易感员工,不再负责带状疱疹和播散性带状疱疹患者。风疹抗体滴度的流行没有性别差异。我们的员工抗体滴度阳性符合腮腺炎标准的比率为59.3%,仅次于麻疹,是第二低的,而人们越来越担心麻疹旁边的医院可能会发生感染传播。通过调查抗体滴度不符合标准的20多岁员工的疫苗接种史,我们确定66.7%的员工接种过麻疹疫苗,56.5%的员工接种过风疹疫苗。这表明存在疫苗失效,包括一次和二次疫苗失效。重要的是调查抗体滴度和疫苗接种史,以确定是否获得免疫。今后,我们需要回顾所有员工的疫苗接种史,并根据结果推荐疫苗接种。
{"title":"Examination of the Antibody Prevalence of Viral Diseases (Measles, Rubella, Chickenpox, and Mumps) among Staff in a Cancer Specialty Hospital","authors":"Haruka Utsunomiya, Izumi Nakagawa, M. Hamada","doi":"10.4058/jsei.36.105","DOIUrl":"https://doi.org/10.4058/jsei.36.105","url":null,"abstract":"We examined the antibody prevalence of epidemic viral diseases among the employees (618) in our hospital using antibody titers measured for all of them. As a result, it was found that ap-proximately 70% of the employees should take measures such as investigation of vaccination history and additional vaccination though no one had negative antibody titers of all viral infections. The rate of our employees with a positive antibody titer meeting the measles criteria was 46.1% of the total. It showed that the risk of an outbreak was high if the measles was brought to our institution. However, more than 90% of the employees with a positive antibody titer met the chickenpox criteria, making it possible to release a small number of employees with being sus-ceptible to chicken pox from taking charge of patients with herpes zoster and disseminated herpes zoster. There was no gender difference in the prevalence of rubella antibody titers. The rate of our employees with a positive antibody titer meeting the mumps criteria was 59.3% of the to-tal, the second lowest after measles, while a concern had been growing about a possibility of an infection spread in the hospital next to measles. As a result of investigating a vaccination history of the employees in their 20s whose antibody titers did not meet the criteria, we confirmed that 66.7% of the employees had vaccination for measles and 56.5% for rubella. This suggested the presence of vaccine failure, including primary and secondary vaccine failure. It is important to investigate both antibody titer and vaccination history to confirm the status of acquisition of immunity. In the future, we need to review the vaccination history of all employees and recommend vaccinations based on the results.","PeriodicalId":414784,"journal":{"name":"Japanese Journal of Infection Prevention and Control","volume":"177 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122928733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Japanese Journal of Infection Prevention and Control
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1